Patents by Inventor William E. Gillanders

William E. Gillanders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR DIAGNOSING EPITHELIAL CELL CANCER
    Publication number: 20110201012
    Abstract: Provided is a method for detecting metastases of epithelial cancers, comprising detecting in non-primary tissue overexpression of a nucleic acid of KS1/4, or detecting in non-primary tissue overexpression of a combination of nucleic acids of KS1/4 and PIP, of nucleic acids of KS1/4 and mam, of nucleic acids of PIP and mam, of nucleic acids of KS1/4, PIP and mam, or of nucleic acids of KS1/4 and lunx, the overexpression of a nucleic acid of KS1/4, or the overexpression of a combination of nucleic acids of KS1/4 and PIP, of nucleic acids of KS1/4 and mam, of nucleic acids of PIP and mam, of nucleic acids of KS1/4, PIP and mam, or of nucleic acids of KS1/4 and lunx in non-primary tissue being correlated with metastases of epithelial cancers.
    Type: Application
    Filed: October 19, 2010
    Publication date: August 18, 2011
    Inventors: MICHAEL MITAS, David J. Cole, William E. Gillanders, Michael Wallace
  • Enhanced detection of RNA using a panel of truncated gene-specific primers for reverse transcription
    Patent number: 7981616
    Abstract: The present invention provides truncated gene-specific primers in panels that can be used during the reverse transcription step of RT-PCR to increase signal detection of cancer gene markers in a tissue sample. Also provided are forward and reverse primers for RT-PCR. Methods of using the primers are also provided.
    Type: Grant
    Filed: February 25, 2005
    Date of Patent: July 19, 2011
    Assignee: MUSC Foundation for Research Development
    Inventors: Michael Mitas, David J. Cole, William E. Gillanders, Kaidi Mikhitarian
  • Methods and compositions for diagnosing epithelial cell cancer
    Patent number: 7824857
    Abstract: Provided is a method for detecting metastases of epithelial cancers, comprising detecting in non-primary tissue overexpression of a nucleic acid of KS1/4, or detecting in non-primary tissue overexpression of a combination of nucleic acids of KS1/4 and PIP, of nucleic acids of KS1/4 and mam, of nucleic acids of PIP and mam, of nucleic acids of KS1/4, PIP and mam, or of nucleic acids of KS1/4 and lunx, the overexpression of a nucleic acid of KS1/4, or the overexpression of a combination of nucleic acids of KS1/4 and PIP, of nucleic acids of KS1/4 and mam, of nucleic acids of PIP and mam, of nucleic acids of KS1/4, PIP and mam, or of nucleic acids of KS1/4 and lunx in non-primary tissue being correlated with metastases of epithelial cancers.
    Type: Grant
    Filed: December 2, 2004
    Date of Patent: November 2, 2010
    Assignee: MUSC Foundation for Research Development
    Inventors: Michael Mitas, David J. Cole, William E. Gillanders, Michael Wallace
  • Methods and compositions for diagnosing epithelial cell cancer
    Publication number: 20080241849
    Abstract: Provided is a method for detecting metastases of epithelial cancers, comprising detecting in non-primary tissue overexpression of a nucleic acid of KS1/4, or detecting in non-primary tissue overexpression of a combination of nucleic acids of KS1/4 and PIP, of nucleic acids of KS1/4 and mam, of nucleic acids of PIP and mam, of nucleic acids of KS1/4, PIP and mam, or of nucleic acids of KS1/4 and lunx, the overexpression of a nucleic acid of KS1/4, or the overexpression of a combination of nucleic acids of KS1/4 and PIP, of nucleic acids of KS1/4 and mam, of nucleic acids of PIP and mam, of nucleic acids of KS1/4, PIP and mam, or of nucleic acids of KS1/4 and lunx in non-primary tissue being correlated with metastases of epithelial cancers.
    Type: Application
    Filed: May 13, 2008
    Publication date: October 2, 2008
    Inventors: Michael Mitas, David J. Cole, William E. Gillanders, Michael Wallace
  • Enhanced Detection of Rna Using a Panel of Truncated Gene-Specific Primers for Reverse Transcription
    Publication number: 20080233563
    Abstract: The present invention provides truncated gene-specific primers in panels that can be used during the reverse transcription step of RT-PCR to increase signal detection of cancer gene markers in a tissue sample. Also provided are forward and reverse primers for RT-PCR. Methods of using the primers are also provided.
    Type: Application
    Filed: February 25, 2005
    Publication date: September 25, 2008
    Applicant: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
    Inventors: Michael Mitas, David J. Cole, William E. Gillanders, Kaidi Mikhitarian